JP2008501741A5 - - Google Patents

Download PDF

Info

Publication number
JP2008501741A5
JP2008501741A5 JP2007526245A JP2007526245A JP2008501741A5 JP 2008501741 A5 JP2008501741 A5 JP 2008501741A5 JP 2007526245 A JP2007526245 A JP 2007526245A JP 2007526245 A JP2007526245 A JP 2007526245A JP 2008501741 A5 JP2008501741 A5 JP 2008501741A5
Authority
JP
Japan
Prior art keywords
methylphenidate
pellet
layer
buffer system
active layer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007526245A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008501741A6 (ja
JP2008501741A (ja
Filing date
Publication date
Priority claimed from ES200401412A external-priority patent/ES2261006B1/es
Application filed filed Critical
Publication of JP2008501741A publication Critical patent/JP2008501741A/ja
Publication of JP2008501741A6 publication Critical patent/JP2008501741A6/ja
Publication of JP2008501741A5 publication Critical patent/JP2008501741A5/ja
Withdrawn legal-status Critical Current

Links

JP2007526245A 2004-06-10 2005-06-01 多層制御放出性メチルフェニデートペレット Withdrawn JP2008501741A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ESP200401412 2004-06-10
ES200401412A ES2261006B1 (es) 2004-06-10 2004-06-10 Pellet multicapa de liberacion controlada de metilfenidato.
PCT/EP2005/005874 WO2005120468A1 (en) 2004-06-10 2005-06-01 Multi-layered controlled-release methylphenidate pellet

Publications (3)

Publication Number Publication Date
JP2008501741A JP2008501741A (ja) 2008-01-24
JP2008501741A6 JP2008501741A6 (ja) 2008-05-29
JP2008501741A5 true JP2008501741A5 (enExample) 2008-07-10

Family

ID=34969228

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007526245A Withdrawn JP2008501741A (ja) 2004-06-10 2005-06-01 多層制御放出性メチルフェニデートペレット

Country Status (7)

Country Link
US (1) US20080069872A1 (enExample)
EP (1) EP1753410A1 (enExample)
JP (1) JP2008501741A (enExample)
CA (1) CA2566497A1 (enExample)
ES (1) ES2261006B1 (enExample)
IL (1) IL179338A0 (enExample)
WO (1) WO2005120468A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101288659B (zh) * 2007-04-18 2014-06-18 王雷波 一种胃内漂浮型微丸及其制备方法
EP2044932A1 (en) 2007-10-04 2009-04-08 Laboratorios del Dr. Esteve S.A. Mechanical protective layer for solid dosage forms
CA2742680C (en) * 2008-11-07 2013-12-31 Samyang Corporation Pharmaceutical compositions for release control of methylphenidate
EP2555756B1 (en) * 2010-04-07 2018-08-22 Lupin Limited Controlled release pharmaceutical compositions of tapentadol
BR112013024401B1 (pt) * 2011-03-23 2022-01-11 Ironshore Pharmaceuticals & Development, Inc Composição farmacêutica sólida oral compreendendo um ingrediente ativo estimulante do sistema nervoso central e o uso terapêutico da mesma
KR101334947B1 (ko) * 2011-11-28 2013-11-29 이승우 서방성 정제 및 그 제조방법
AU2013302657B2 (en) 2012-08-15 2018-08-09 Tris Pharma, Inc. Methylphenidate extended release chewable tablet
CA2936741C (en) * 2014-10-31 2018-11-06 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
TWI634909B (zh) * 2015-08-13 2018-09-11 生達化學製藥股份有限公司 Long-acting sustained-release medicine composition and preparation method thereof
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
US12458592B1 (en) 2017-09-24 2025-11-04 Tris Pharma, Inc. Extended release amphetamine tablets
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
BR112022005901A2 (pt) * 2019-09-27 2022-06-28 Hercules Llc Composição de revestimento de película branca isenta de dióxido de titânio, processo para preparar a mesma e método de uso da mesma
CN111557929B (zh) * 2020-05-15 2021-12-07 河南中帅医药科技股份有限公司 一种盐酸右哌甲酯多重释放制剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395626A (en) * 1994-03-23 1995-03-07 Ortho Pharmaceutical Corporation Multilayered controlled release pharmaceutical dosage form
US5837284A (en) * 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
HK1046638B (zh) * 1998-06-03 2006-02-24 阿尔扎有限公司 提供药物长效治疗的方法和装置
US6419960B1 (en) * 1998-12-17 2002-07-16 Euro-Celtique S.A. Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
US6562375B1 (en) * 1999-08-04 2003-05-13 Yamanouchi Pharmaceuticals, Co., Ltd. Stable pharmaceutical composition for oral use
US6344215B1 (en) 2000-10-27 2002-02-05 Eurand America, Inc. Methylphenidate modified release formulations

Similar Documents

Publication Publication Date Title
JP2008513467A5 (enExample)
JP2010090168A5 (enExample)
JP2010529999A5 (enExample)
WO2008019871A3 (de) Neue salze des wirkstoffs rasagilin
WO2008114800A8 (en) Solid preparation comprising 2- [ [6- [ (3r) -3-amino-1-piperidinyl] -3, 4-dihydro-3-methyl-2, 4-dioxo-1 (2h) -pyrimidinyl] methyl] -4-fluorobenzonitrile
HRP20171384T4 (hr) Farmaceutski pripravak
WO2009059701A3 (de) Retardtabletten mit hydromorphon
HRP20110094T8 (en) Solid preparation comprising alogliptin and pioglitazone
WO2009041651A1 (ja) 速崩壊性固形製剤
JP2011519967A5 (enExample)
RU2009126767A (ru) Производное 1-фенил-1-тио-d-глюцитола
WO2008143240A1 (ja) 特定の有機酸を含有する経口製剤並びに経口製剤の溶出性及び化学的安定性の改善方法
PE20130210A1 (es) Composicion farmaceutica solida que comprende un derivado de bencimidazol y un agente de control de ph
JP2008512527A5 (enExample)
WO2007128478A3 (en) Pharmaceutical composition
WO2007143163A3 (en) Pharmaceutical compositions for sustained release of phenyephrine
JP2014024874A5 (enExample)
CA2601501A1 (en) Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
MX2007008141A (es) Composicion farmaceutica de sustancias labiles en medio acido.
CY1109865T1 (el) Συνθεσεις βαλσαρτανης
WO2007072495A3 (en) Coated tablets having prolonged gastric retention
CL2011000187A1 (es) Preparacion farmaceutica que comprende (5-metil-2-oxo-1,3-dioxol-4il)metil 2-etoxi-1-{[2,{5-oxo-4,5-dihidro-1,2,4-oxadiazol-3-il)bifenil4il]metil}-1h-benzimidazol-7-carboxilato, un agente de control de ph entre 2 y 5 y un diuretico; metodo para estabilizar; metodo para mejorar disolucion, util en enfermedades inducidas por angiotensina ii.
JP2008515980A5 (enExample)
WO2006049564A8 (en) New modified release pellet formulations for proton pump inhibitors
CL2007003451A1 (es) Composicion farmaceutica solida oral que comprende un principio activo y polivinilpirrolidona (pvp) entre 1,0-25%, cpaa entre 0,5-10%, el principio activo consiste en una sal hidrosoluble de metal alcalino, de metal alcalino-terreo, una sal de mezcla